The sea-lice drug emamectin benzoate was found in 97% of sediment samples around Scottish salmon farms and harmed seabed crustaceans, and sea lice in the Pacific have evolved resistance to it.
Original statement
رصد Bloodworth الإيموكتين بنزوات (دواء قمل البحر) في 97% من رواسب القاع حول مزارع شتلاند الإسكتلندية، فيما أظهرت Bateman أنّ قمل البحر في المحيط الهادي طوّر مقاومة تجاه هذا الدواء نفسه
verbatim according to source. Translation by the project; the Arabic wording is authoritative.
Translation
The sea-lice drug emamectin benzoate was found in 97% of sediment samples around Scottish salmon farms and harmed seabed crustaceans, and sea lice in the Pacific have evolved resistance to it.
Origin
- Source status
- Archive editors
- Attribution
- Archive editors (eltayebat.com)
- Origin
- https://eltayebat.com/rule/farmed-fish/
- Attribution uncertainty
- Archive editorial narrative and featured-study cards, written by the archive operators; study selection is the archive's, not necessarily Elawady's.
- Claimed mechanism
Drug residues in sediment; resistance selection.
- Claimed health effect
Ecological harm; implied human risk.
- Population concerned
Environment
- Geographic restriction by Elawady
none found
Scientific assessment
True – The statement is supported by robust evidence.
Certainty of evidence: moderate – Further research may still affect the assessment.
1. What was claimed?
Sea-lice drug pollution and resistance.
2. What is demonstrably correct?
Emamectin benzoate in 97% of samples and strongest negative effect on crustacean abundance (A-FSH-15); decreased EMB sensitivity in Pacific lice since 2010 (A-FSH-16).
3. What is wrong or exaggerated?
The archive attributes A-FSH-16 to 'Bateman'; the first author is Godwin SC (Bateman AW is second author). The findings are environmental; they are not evidence of harm to people eating salmon. The EU sets a maximum residue limit for emamectin of 100 µg/kg in fin fish muscle and skin (I-RES-01).
4. What remains unclear?
Consumer exposure to emamectin residues was not studied in the cited papers.
5. Which studies support it?
A-FSH-15 (emamectin benzoate in 97% of Scottish sediment samples; negative effect on crustacean abundance); A-FSH-16 (resistance sub-claim only: Pacific salmon-lice EC50 rose 5-fold in males and 16-fold in females at one farm between 2010 and 2021, with treatment failures; 34 bioassays, 11 farms).
6. Which studies contradict it?
None against the environmental findings. They do not show harm to consumers; the EU sets a maximum residue limit for emamectin in fin fish (I-RES-01).
7. What applies to Germany and Europe?
EU MRL 100 µg/kg for emamectin B1a in fin fish (I-RES-01).
8. What is known about Egypt?
Not relevant (no salmon farming).
9. What practical conclusion is appropriate?
An environmental argument; not a demonstrated food-safety hazard.
Assessment details
- Rationale for certainty of evidence
Both findings are reported in peer-reviewed studies as summarised. They concern the environment and parasite resistance, not consumer health.
- Source quality
Peer-reviewed field studies.
- Regional transferability
Applies to salmon farming regions (Scotland, Norway, Canada, Chile).
- Individual exceptions
Not applicable.
- Regional scope of the claim
- depends on production conditions
- Last reviewed
- 26 October 2026 provisional
Scientific evidence in detail
Scientifically well supported – The claim agrees with consistent, high-quality evidence.
Research question: Is emamectin benzoate widespread in sediments near salmon farms, harmful to seabed crustaceans, and are Pacific sea lice resistant to it?
Research question in detail (PECO)
- Population
- Seabed fauna; sea lice
- Intervention or exposure
- Emamectin benzoate use
- Comparison
- Unexposed sites / earlier years
- Geographic scope
- Salmon-farming regions
- Outcomes
- Sediment detection
- Crustacean abundance
- Resistance
Study results as reported by the authors. Our assessment follows below.
What speaks for the claim?
Sea-lice drug in seabed near salmon farms
Bloodworth JW et al.. Sci Total Environ 2019 · PMID 30878944 · DOI 10.1016/j.scitotenv.2019.02.430 Cross-sectional studyabstract checkedScottish study: EMB in 97% of sediment samples, strongest negative effect on crustaceans.
- Actual result
- As reported.
- Methodological quality
- moderate
- Relevance
- direct
- Limitations
- Observational.
Sea-lice drug harms seabed life near Norwegian salmon farms
Arnberg M et al.. Environ Sci Technol 2026 · PMID 41566218 · DOI 10.1021/acs.est.5c11181 Cross-sectional studyabstract checkednewly addedNorwegian 2026 study: EMB widespread and persistent; strongest effect on benthic abundance; harm possibly up to 1 km.
- Actual result
- Effects at 0.2 ng/g.
- Methodological quality
- moderate
- Relevance
- direct
- Limitations
- Observational.
Sea lice resistant to treatment (Canada)
Godwin SC et al.. Sci Rep 2022 · PMID 35347162 · DOI 10.1038/s41598-022-07464-1 Otherfull text, structured risk-of-bias assessmentPacific salmon lice EC50 rose 5- to 16-fold at one farm 2010-2021.
- Actual result
- As reported.
- Methodological quality
- moderate
- Relevance
- direct
- Limitations
- Limited farms.
What speaks against the claim?
No high-quality evidence against the claim was found.
What does the overall evidence say?
Editorial assessment based on the studies above – not itself a study result.
Which position is better supported?
Correct for the environment; no evidence of consumer harm.
Why some studies weigh more
Two independent field studies.
Is a causal relationship established? Probable Consistent field associations plus toxicity to crustaceans.
Remaining uncertainty
Consumer exposure (EU MRL 100 µg/kg).
Justified conclusion
True as environmental claim.
Does this depend on the country?
- General biological effects
- Not applicable.
- Eating habits
- Not applicable.
- Origin of the food
- Salmon farms in Scotland, Norway, Canada.
- Contaminants
- EMB in sediment.
- National production conditions
- No salmon farming in Egypt.
- Legal rules
- EU MRL for emamectin in fin fish.
- Actual monitoring data
- Not applicable.
A regional difference that changes the conclusion is not supported by robust data.
Certainty of the overall evidence (GRADE, simplified)
- Main outcome
- Environmental effects of EMB
- Starting level
- low (observational studies)
- Reasons for upgrading
- replication in two countries
- Result
- moderate
Simplified assessment by a single reviewer, following the GRADE approach; not a formal GRADE panel. GRADE rates the body of evidence for one outcome, not individual studies.
Search strategy
Documented literature searches for this review (search strings in the original database syntax).
| Database | Date | Search | Looking for | Hits | Included |
|---|---|---|---|---|---|
| Europe PMC | 26 October 2026 | (emamectin) AND (residue*) AND (salmon) AND (fillet OR muscle OR consumer OR food) | both directions | 54 |
How deeply was this checked?
4 linked studies: 1 checked in full text (1 of them with a structured risk-of-bias assessment), 3 on the basis of the abstract, 0 bibliographically only. No formal assessment with two independent reviewers and no independent human expert review has taken place yet.
Last scientific review: 26 October 2026
History of the verdict
- 25 October 2026 · Phase 1 · Initial assessment: True (moderate)
- 26 October 2026 · Phase 4 (systematic evidence review) · Re-examined with extended evidence; verdict unchanged: True (moderate)
Replication strengthens but does not change the verdict.
New sources: I-FSH-115
In plain language
Salmon farms treat sea lice with a drug called emamectin benzoate. A Scottish study found it in almost all seabed samples near farms, where it harmed small crustaceans. In Canada, sea lice have become resistant to it. These are real environmental problems. The studies did not examine risks to people who eat salmon.
Studies on this claim
Studies supporting the claim (3)
-
Sea-lice drug in seabed near salmon farms
Bloodworth JW et al.. Sci Total Environ 2019 · PMID 30878944 · DOI 10.1016/j.scitotenv.2019.02.430Cross-sectional studycited by the Tayebat archiveabstract checked★ key studyThe drug was found in 97% of seabed samples and was linked to fewer small crustaceans.
Does the study support the specific claim? Yes · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Assess drug impact on seabed life.
- How was the study done?
Field sampling, models.
- How many people, animals or samples were studied?
8 farms.
- What was actually found?
Widespread; harms crustaceans.
- How large was the observed effect?
97% detection.
- What do the results mean in everyday life?
Environmental problem.
- What are the study's limitations?
Observational.
- What does it say about Elawady's specific claim?
Supports environmental claim only.
- Do the results apply to Germany and Europe?
Moderate.
- What can explicitly not be concluded from this study?
Human health effects.
-
Sea lice resistant to treatment (Canada)
Godwin SC et al.. Sci Rep 2022 · PMID 35347162 · DOI 10.1038/s41598-022-07464-1Othercited by the Tayebat archivefull text, structured risk-of-bias assessmentPacific salmon lice have become much less sensitive to emamectin since 2010.
Does the study support the specific claim? Yes · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Test lice resistance.
- How was the study done?
Bioassays.
- How many people, animals or samples were studied?
34 bioassays from 11 farms; 73 treatments (2010-2021).
- What was actually found?
Lice needed up to 5-16 times more drug to be killed in 2021 than in 2010; after 2019, 41% of treatments left more than half of the lice.
- What do the results mean in everyday life?
Treatment works less.
- What are the study's limitations?
One region.
- What does it say about Elawady's specific claim?
Supports.
- Do the results apply to Germany and Europe?
Low.
- What can explicitly not be concluded from this study?
Anything about drug residues in salmon or risk to consumers.
-
Sea-lice drug harms seabed life near Norwegian salmon farms
Arnberg M et al.. Environ Sci Technol 2026 · PMID 41566218 · DOI 10.1021/acs.est.5c11181Cross-sectional studyindependent cross-checkabstract checkedEmamectin benzoate was widespread in sediments and had the strongest negative effect on seabed animals, especially crustaceans.
EMB harms seabed crustaceans in Norway as well.
Does the study support the specific claim? Yes · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Map EMB and its effects.
- How was the study done?
Field sampling and modelling.
- How many people, animals or samples were studied?
Norwegian farm sites.
- What was actually found?
Persistent EMB; reduced diversity.
- How large was the observed effect?
Effects at 0.2 ng/g.
- What do the results mean in everyday life?
An environmental problem.
- What are the study's limitations?
No consumer data.
- What does it say about Elawady's specific claim?
Confirms the environmental harm.
- Do the results apply to Germany and Europe?
High.
- What can explicitly not be concluded from this study?
Risk to people eating salmon.
No study in this group is marked as key.
Studies contradicting or limiting the claim (0)
No studies in this group.
Studies with mixed or unclear results (1)
-
EU limits for veterinary drug residues
European Commission. Official Journal of the EU 2010Guideline / position statementindependent cross-checkabstract checkedThe EU sets residue limits (e.g. emamectin 100 µg/kg in fish) and bans some drugs such as chloramphenicol and nitrofurans.
Does the study support the specific claim? Unclear · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Set MRLs.
- How was the study done?
Regulation.
- What was actually found?
MRLs and prohibitions.
- What do the results mean in everyday life?
Residues are legally limited.
- What are the study's limitations?
As-adopted text.
- What does it say about Elawady's specific claim?
Context.
- Do the results apply to Germany and Europe?
High.
No study in this group is marked as key.
Regional context
Germany / EU
EU MRL 100 µg/kg for emamectin B1a in fin fish (I-RES-01).
Egypt
Not relevant (no salmon farming).
- Food-safety governance and official controls
- Pesticide residues in fruit and vegetables on the EU/German market (incl. imports from Egypt)
- Pesticide residues in produce sold on the Egyptian domestic market
- Antibiotic (veterinary drug) residues in poultry meat and eggs
- Antimicrobial use in food animals and antibiotic growth promoters
- Hormones in poultry, meat, milk and farmed fish
- Dioxins, PCBs and PFAS in eggs and other animal foods
- Aflatoxin M1 in milk and dairy products
- Aflatoxins in groundnuts (peanuts)
- Heavy metals in fish
- Farmed fish (aquaculture): drugs, water source and controls
- Import controls and the meaning of RASFF notifications for Egyptian products
What applies in my country?
General scientific assessment
True Correct for the environment; it does not show harm to consumers.
The following areas of food safety are relevant to this statement:
- Pesticides and pesticide residues
- Veterinary medicines and antibiotics
- Hormonal growth promoters
- Contaminants (heavy metals, PFAS, PCBs, dioxins, nitrate)
- Pathogens (Salmonella, Campylobacter, etc.)
- Animal husbandry and feed
Eggs · Poultry · Dairy · Fish and seafood · Red meat · Fruit and vegetables
Choose a country to see the checked information for it.
Limits: legal rules describe what is allowed, not what every single food contains. Measurement data come from samples and are meaningful only together with their method details.
Country of residence or purchase Compare with another country
References
- Negative effects of the sea lice therapeutant emamectin benzoate at low concentrations on benthic communities around Scottish fish farms.. Bloodworth JW et al.. Sci Total Environ 2019 · PMID 30878944 · DOI 10.1016/j.scitotenv.2019.02.430
- Salmon lice in the Pacific Ocean show evidence of evolved resistance to parasiticide treatment.. Godwin SC et al.. Sci Rep 2022 · PMID 35347162 · DOI 10.1038/s41598-022-07464-1
- Ecological Impacts of Emamectin Benzoate, a Sea Lice Therapeutant, on Benthic Communities in the Vicinity of Norwegian Aquaculture Facilities.. Arnberg M et al.. Environ Sci Technol 2026 · PMID 41566218 · DOI 10.1021/acs.est.5c11181
- Commission Regulation (EU) No 37/2010 of 22 December 2009 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin. European Commission. Official Journal of the EU 2010